ChemComm
Communication
(c) A. Thangadurai, M. Minu, S. Wakode, S. Agrawal and
B. Narasimhan, Med. Chem. Res., 2012, 21, 1509.
2 For reviews, see: (a) M. J. Clarke, Coord. Chem. Rev., 2003, 236, 209;
(b) G. Rapenne, Inorg. Chim. Acta, 2009, 362, 4276.
3 (a) P. Jacobson and L. Huber, Ber. Dtsch. Chem. Ges., 1908, 41, 660;
(b) W. Stadlbauer, Sci. Synth., 2002, 12, 227 and references therein.
4 (a) S. Caron and E. Vazquez, Synthesis, 1999, 588; (b) K. Jukin,
M. C. Hsu, D. Fernando and M. R. Leanna, J. Org. Chem., 2006,
71, 8166. For related examples, see: (c) C. M. Counceller, C. C.
Eichman, B. C. Wray and J. P. Stambuli, Org. Lett., 2008, 10, 1021;
(d) A. C. Sather, O. B. Berryman and J. Rebek Jr., Org. Lett., 2012,
Scheme 5 Application to the formal synthesis of WAY-169916. a Reaction
conditions: 1-nitro-2-(trifluoromethyl)benzene (0.3 mmol), N-tosylhydrazone
(0.45 mmol), NaH (1.35 mmol), TBAB (0.3 mmol), DMF (2.0 mL), 110 1C.
´
14, 1600; (e) I. Thome, C. Besson, T. Kleine and C. Bolm, Angew.
Chem., Int. Ed., 2013, 52, 7509.
5 (a) T. Jin and Y. Yamamoto, Angew. Chem., Int. Ed., 2007, 46, 3323;
(b) Z. Liu, F. Shi, P. D. G. Martinez, C. Raminelli and R. C. Larock,
J. Org. Chem., 2008, 73, 219; (c) T. Jin, F. Yang and Y. Yamamoto,
Collect. Czech. Chem. Commun., 2009, 74, 957; (d) C. Spiteri,
S. Keeling and J. E. Moses, Org. Lett., 2010, 12, 3368; (e) P. Li,
J. Zhao, C. Wu, R. C. Larock and F. Shi, Org. Lett., 2011, 13, 3340;
( f ) N. A. Markina, A. V. Dubrovskiy and R. C. Larock, Org. Biomol.
Chem., 2012, 10, 2409; (g) P. Li, C. Wu, J. Zhao, D. C. Rogness and
F. Shi, J. Org. Chem., 2012, 77, 3149.
6 For selected examples, see: (a) J. J. Song and N. K. Yee, Tetrahedron
Lett., 2001, 42, 2937; (b) C. S. Cho, D. K. Lim, N. H. Heo, T.-J. Kim
and S. C. Shim, Chem. Commun., 2004, 104; (c) K. Inamoto, T. Saito,
M. Katsuno, T. Sakamoto and K. Hiroya, Org. Lett., 2007, 9, 2931;
1H-indazoles (1i–j) were obtained in low yields, presumably
attributed to the ortho effect.15
Next, we examined the substrate scope of the N-tosylhydrazones.
For the reactions with 1,3-dinitrobenzene, N-tosylhydrazones derived
from aldehydes with weak electron-donating or -withdrawing groups
worked smoothly (1k–l). However, those derived from the aldehydes
bearing strong electron-withdrawing or bulky substituents gave only
diminished yields of the corresponding products (1m–n). For the
reactions with 1-chloro-4-nitrobenzene, the results were somewhat
similar (1o–s). N-Tosylhydrazones derived from heteroaromatic
aldehydes also worked well to give the corresponding products in
moderate yields (1t–u). Besides, the N-tosylhydrazones derived from
alkyl aldehydes and alkenyl aldehydes could also be used to afford
3-alkyl or alkenyl-substituted indazoles in good yields (1v–y).
Finally, the reaction with 1-nitro-2-(trifluoromethyl)benzene
afforded moderate yield of the product (1z). For one of the
products 1k, the structure is unambiguously confirmed by X-ray
diffraction analysis.16
WAY-169916 is the first example of an ER ligand that has
broad anti-inflammatory activity in vivo with the potential use
in the treatment of rheumatoid arthritis but lacks the classical
proliferative effects associated with estrogens.17 The access to
this molecule from previous reports calls for multi-step synthesis.
Herein, the current methodology has been employed to prepare
the key intermediate 3 in one step from the readily available
starting materials (Scheme 5). The intermediate 3 could be easily
transformed to WAY-169916 according to the literature.17c
In conclusion, we have developed a straightforward method
for the synthesis of 1H-indazoles from N-tosylhydrazones and
nitroaromatic compounds. The reaction is efficient and shows
a wide substrate scope. Compared with the existing methods,
ready availability of the starting materials, easy operation, and
no need for transition-metal catalysts are its attractive features.
With these merits, we expect that this methodology would find
applications in the synthesis of 1H-indazoles.
˜
´
´
(d) D. Vina, E. del Olmo, J. L. Lopez-Perez and A. San Feliciano, Org.
Lett., 2007, 9, 525; (e) X. Xiong, Y. Jiang and D. Ma, Org. Lett., 2012,
14, 2552; ( f ) X. Li, L. He, H. Chen, W. Wu and H. Jiang, J. Org.
Chem., 2013, 78, 3636; (g) T. Zhang and W. Bao, J. Org. Chem., 2013,
78, 1317; (h) D.-G. Yu, M. Suri and F. Glorius, J. Am. Chem. Soc., 2013,
135, 8802 and references therein.
´
7 For reviews, see: (a) C. Valdes and J. Barluenga, Angew. Chem., Int.
Ed., 2011, 50, 7486; (b) Z. Shao and H. Zhang, Chem. Soc. Rev., 2012,
41, 560; (c) Q. Xiao, Y. Zhang and J. Wang, Acc. Chem. Res., 2013,
46, 236; (d) Z. Liu and J. Wang, J. Org. Chem., 2013, 78, 10024;
(e) Y. Xia, Y. Zhang and J. Wang, ACS Catal., 2013, 3, 258.
8 (a) X. Zhao, G. Wu, Y. Zhang and J. Wang, J. Am. Chem. Soc., 2011,
133, 3296; (b) T. Yao, K. Hirano, T. Satoh and M. Miura, Angew.
Chem., Int. Ed., 2012, 51, 775; (c) Q. Xiao, L. Ling, F. Ye, R. Tan,
L. Tian, Y. Zhang, Y. Li and J. Wang, J. Org. Chem., 2013, 78, 3879;
(d) Y. Zhang, J. Wang and J. Wang, Synlett, 2013, 1643.
9 W. R. Bamford and T. S. Stevens, J. Chem. Soc., 1952, 4735.
10 For a review, see: H. Pellissier and M. Santelli, Tetrahedron, 2003,
59, 701.
11 The crude product was analyzed by GC and NMR.
12 It has been observed that the colour of the solution remains
unchanged throughout the reaction. Besides, PhCHN2 prepared by
known procedure does not react with 1,3-dinitrobenzene under the
current conditions. These observations indicate that the diazo
intermediate is not be formed in this reaction.
13 For related pyrazole synthesis, see: M. Tang, W. Zhang and Y. Kong,
Org. Biomol. Chem., 2013, 11, 6250 and references therein.
14 (a) T. Kawakami, K. Uehata and H. Suzuki, Org. Lett., 2000, 2, 413;
(b) K. Uehata, T. Kawakami and H. Suzuki, J. Chem. Soc., Perkin
Trans. 1, 2002, 696.
15 M. Charton, J. Am. Chem. Soc., 1969, 91, 6649.
16 CCDC 985185.
17 (a) R. J. Steffan, E. Matelan, M. A. Ashwell, W. J. Moore, W. R. Solvibile,
E. Trybulski, C. C. Chadwick, S. Chippari, T. Kenney, A. Eckert, L. Borges-
Marcucci, J. C. Keith, Z. Xu, L. Mosyak and D. C. Harnish, J. Med. Chem.,
2004, 47, 6435; (b) C. C. Chadwick, S. Chippari, E. Matelan, L. Borges-
Marcucci, A. M. Eckert, J. C. Keith Jr., L. M. Albert, Y. Leathurby, H. A.
Harris, R. A. Bhat, M. Ashwell, E. Trybulski, R. C. Winneker, S. J.
Adelman, R. J. Steffan and D. C. Harnish, Proc. Natl. Acad. Sci. U. S. A.,
2005, 102, 2543; (c) I. A. Murray, G. Krishnegowda, B. C. DiNatale,
C. Flaveny, C. Chiaro, J.-M. Lin, A. K. Sharma, S. Amin and G. H.
Perdew, Chem. Res. Toxicol., 2010, 23, 955.
Notes and references
´
´
1 For reviews, see: (a) H. Cerecetto, A. Gerpe, M. Gonzalez, V. J. Aran and
´
C. O. de Ocariz, Mini-Rev. Med. Chem., 2005, 5, 869; (b) A. Schmidt,
A. Beutler and B. Snovydovych, Eur. J. Org. Chem., 2008, 4073;
This journal is ©The Royal Society of Chemistry 2014
Chem. Commun.